Notably, lysine acetyltransferase 2A (KAT2A) expression is markedly increased in clear cell renal cell carcinoma (ccRCC), where it likely promotes tumour metastasis and proliferation by modulating the immune‐suppressive tumour microenvironment.32 This evidence concerns the gene KAT2A and nonpapillary renal cell carcinoma.